Your session is about to expire
← Back to Search
Incentive-Based Interventions for Smoking Cessation
N/A
Waitlist Available
Led By Maya Vijayaraghavan, MD, MAS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Are 18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will test whether providing incentives for smoking cessation (like cash) to people experiencing homelessness makes them more likely to quit smoking.
Who is the study for?
This trial is for homeless adults who smoke daily, have smoked over 100 cigarettes in their lifetime, and want to quit within six months. They must be getting or willing to start smoking cessation counseling at the Tom Waddell Urban Health Center, be over 18 years old, meet homelessness criteria, and speak English. Pregnant individuals or those with a recent heart attack can't participate.Check my eligibility
What is being tested?
The study tests a contingency management approach that rewards quitting smoking with cash incentives among the homeless. It aims to see if this method is practical and well-received when offered through safety net clinics.See study design
What are the potential side effects?
Since this intervention involves behavioral changes rather than medication, there are no direct side effects like you'd expect from drugs. However, participants may experience typical nicotine withdrawal symptoms such as irritability, cravings, or difficulty concentrating.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Median number of carbon monoxide (CO) negative samples
Median total number of counseling sessions attended
Proportion of the sample retained as a result of retention procedures over time
Secondary outcome measures
Proportion of participants who achieve point prevalence abstinence
Proportion of participants who achieve prolonged abstinence over time
Trial Design
2Treatment groups
Experimental Treatment
Group I: Control GroupExperimental Treatment1 Intervention
Participants who choose to attend smoking cessation in the usual care setting at TWUHC will receive a basic $5 payment for attending each study visit.
Group II: Contingency Management (CM)Experimental Treatment1 Intervention
In addition to receiving usual cessation care at the Tom Waddell Urban Health Center (TWUHC), CM intervention participants with CO-verified abstinence will obtain a CM incentive payment, via gift cards and/or cash redeemable in national retail chains.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,472 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,535 Total Patients Enrolled
Maya Vijayaraghavan, MD, MASPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
400 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can make my own medical decisions and am open to counseling.I cannot use nicotine replacement therapy due to pregnancy or a recent heart attack.I am 18 years old or older.I am attending smoking cessation counseling.
Research Study Groups:
This trial has the following groups:- Group 1: Control Group
- Group 2: Contingency Management (CM)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the overall size of this scientific investigation?
"Affirmative. Clinicaltrials.gov provides evidence that this research is actively accepting participants; the initial posting was on November 9th 2021 and a recent update occurred on April 21st 2022. Two medical centres are recruiting 90 individuals for the study combined."
Answered by AI
Has the registration window for this experiment been opened?
"Affirmative. According to information found on clinicaltrials.gov, this medical research, that was initially posted on November 9th 2021 is currently recruiting for participants. Two sites are looking for 90 patients in total."
Answered by AI
Who else is applying?
What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University of California, San Francisco
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger